References
- Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv 2015;28:219-28
- Global Initiative for Chronic Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (2017). Available from: http://goldcopd.org
- Newman SP. Inhaler treatment options in COPD. Eur Respir Rev 2005;14:102-8
- Svedsater H, Dale P, Garrill K, et al. Qualitative assessment of attributes and ease of use of the Ellipta dry powder inhaler for delivery of maintenance therapy for asthma and COPD. BMC Pulm Med 2013;13:1-14
- Cazzola M, Hanania NA, MacNee W, et al. A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis 2015;10:725-38
- Altman P, Garcia Conde L, Vernon M, et al., eds. Evaluation of Inhaler Device Preference Items in Patients with Chronic Obstructive Pulmonary Disease: a Cognitive Interview Study. Amsterdam, The Netherlands: International Primary Care Respiratory Group (IPCRG), 2016
- Ultibro Breezhaler. Summary of Product Characteristics. November 2017. Novartis Pharmaceuticals UK Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
- Grant AC, Walker R, Hamilton M, et al. The Ellipta dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. J Aerosol Med Pulm Drug Deliv 2015;28:474-85
- Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract 2015;1:1-9
- Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008;3:371-84
- Chrystyn H, Small M, Milligan G, et al. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med 2014;108:358-65
- Chrystyn H, Price DB, Molimard M, et al. Comparison of serious inhaler technique errors made by device-naive patients using three different dry powder inhalers: a randomised, crossover, open-label study. BMC Pulm Med 2016;16:12
- Weldring T, Smith SM. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights 2013;6:61-8
- Dudvarski Ilic A, Zugic V, Zvezdin B, et al. Influence of inhaler technique on asthma and COPD control: a multicenter experience. Int J Chron Obstruct Pulmon Dis 2016;11:2509-17
- Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50:1360-74